Susan Bobulsky
Chief Commercial Officer, Mrd at Adaptive Biotechnologies Corp (ADPT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 6,444389,350 held (−2%) | $30.00 | $193K | -11.7% |
| Sep 17SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 1,195395,794 held (−0%) | $27.00 | $32K | -1.9% |
| Aug 12SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 3,000396,989 held (−1%) | $25.00 | $75K | +6.0% |
| Aug 3SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 1,299399,989 held (−0%) | $24.00 | $31K | +10.4% |
| Jul 20SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 5,000401,288 held (−1%) | $23.00 | $115K | +15.2% |
| Jul 6SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 487406,288 held (−0%) | $22.00 | $11K | +20.4% |
| Jun 29SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 5,000406,775 held (−1%) | $20.50 | $102K | +29.2% |
| Jun 15SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 5,000411,775 held (−1%) | $19.00 | $95K | +39.4% |
| Jun 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 11,000416,775 held (−3%) | $18.00 | $198K | +47.2% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell | 41,338427,775 held (−9%) | $13.17 | $544K | +101.1% |
- Sell
Chief Commercial Officer, Mrd Susan Bobulsky sold $193K of ADPT at $30.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer, Mrd Susan Bobulsky sold $32K of ADPT at $27.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer, Mrd Susan Bobulsky sold $75K of ADPT at $25.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer, Mrd Susan Bobulsky sold $31K of ADPT at $24.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer, Mrd Susan Bobulsky sold $115K of ADPT at $23.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer, Mrd Susan Bobulsky sold $11K of ADPT at $22.00 — pre-scheduled 10b5-1 plan sale.